PHARMA VALUE DEMONSTRATION BIDCO LIMITED
Company number 12674221
- Company Overview for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221)
- Filing history for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221)
- People for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221)
- Charges for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221)
- More for PHARMA VALUE DEMONSTRATION BIDCO LIMITED (12674221)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
04 Nov 2024 | AA |
Total exemption full accounts made up to 31 December 2023
This document is being processed and will be available in 10 days.
|
|
04 Nov 2024 | PARENT_ACC |
Consolidated accounts of parent company for subsidiary company period ending 31/12/23
This document is being processed and will be available in 10 days.
|
|
04 Nov 2024 | AGREEMENT2 |
Notice of agreement to exemption from audit of accounts for period ending 31/12/23
This document is being processed and will be available in 10 days.
|
|
04 Nov 2024 | GUARANTEE2 |
Audit exemption statement of guarantee by parent company for period ending 31/12/23
This document is being processed and will be available in 10 days.
|
|
11 Jul 2024 | CS01 | Confirmation statement made on 15 June 2024 with no updates | |
12 Mar 2024 | TM01 | Termination of appointment of Eugene Gorbach as a director on 15 December 2023 | |
12 Mar 2024 | TM01 | Termination of appointment of Michael Bernstein as a director on 31 December 2023 | |
01 Feb 2024 | TM01 | Termination of appointment of Mark Bentley as a director on 31 December 2023 | |
01 Feb 2024 | AP01 | Appointment of Mr Michael Madden as a director on 15 December 2023 | |
05 Jan 2024 | AA | Audit exemption subsidiary accounts made up to 31 December 2022 | |
05 Jan 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 31/12/22 | |
05 Jan 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 31/12/22 | |
05 Jan 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 31/12/22 | |
26 Jun 2023 | CS01 | Confirmation statement made on 15 June 2023 with updates | |
25 Apr 2023 | AD01 | Registered office address changed from 31 Old Nichol Street London E2 7HR England to Great Suffolk Yard 127-131 Great Suffolk Street London SE1 1PP on 25 April 2023 | |
02 Mar 2023 | SH01 |
Statement of capital following an allotment of shares on 10 February 2023
|
|
13 Dec 2022 | AA | Full accounts made up to 31 December 2021 | |
14 Nov 2022 | RESOLUTIONS |
Resolutions
|
|
13 Sep 2022 | AD01 | Registered office address changed from Queens House 8-9 Queen Street London EC4N 1SP England to 31 Old Nichol Street London E2 7HR on 13 September 2022 | |
28 Jul 2022 | CS01 | Confirmation statement made on 15 June 2022 with no updates | |
11 Mar 2022 | AP01 | Appointment of Mr Mark Bentley as a director on 10 March 2022 | |
10 Mar 2022 | TM01 | Termination of appointment of Stephen Mclean as a director on 31 December 2021 | |
26 Oct 2021 | AA | Full accounts made up to 31 December 2020 | |
05 Aug 2021 | AA01 | Previous accounting period shortened from 30 June 2021 to 31 December 2020 | |
16 Jul 2021 | CS01 | Confirmation statement made on 15 June 2021 with updates |